Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Willson

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
Cancer Research|December 15, 1994
Deletion of p16 and p15 genes in brain tumorsJ Jen, J W Harper, S H Bigner, et al.
The Journal of Biological Chemistry|November 13, 1998
Autocrine transforming growth factor alpha provides a growth advantage to malignant cells by facilitating re-entry into the cell cycle from suboptimal growth statesD Jiang, H Yang, J K Willson, et al.
Gynecologic Oncology|July 3, 2015
Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signalingJianjun Han, Lu Zhang, Hui Guo, et al.
Cancer Treatment Reports|December 1, 1987
Phase I study of taxol administered as a short i.v. infusion daily for 5 daysJ L Grem, K D Tutsch, K J Simon, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1993
Phase II multicenter evaluation of prolonged murine monoclonal antibody 17-1A therapy in pancreatic carcinomaL M Weiner, E Harvey, K Padavic-Shaller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluationA Dowlati, J Haaga, S C Remick, et al.
The Journal of Biological Chemistry|October 21, 1994
Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cellsL Sun, G Wu, J K Willson, et al.
Cancer Research|April 1, 1989
Methotrexate and dipyridamole combination chemotherapy based upon inhibition of nucleoside salvage in humansJ K Willson, P H Fischer, S C Remick, et al.
Cancer Research|May 27, 1999
O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repairT P Spiro, S L Gerson, L Liu, et al.
Cancer Research|July 1, 1996
Evaluation of the FHIT gene in colorectal cancersS Thiagalingam, N A Lisitsyn, M Hamaguchi, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Cancer Research|December 15, 1994
Deletion of p16 and p15 genes in brain tumorsJ Jen, J W Harper, S H Bigner, et al.
The Journal of Biological Chemistry|November 13, 1998
Autocrine transforming growth factor alpha provides a growth advantage to malignant cells by facilitating re-entry into the cell cycle from suboptimal growth statesD Jiang, H Yang, J K Willson, et al.
Gynecologic Oncology|July 3, 2015
Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signalingJianjun Han, Lu Zhang, Hui Guo, et al.
Cancer Treatment Reports|December 1, 1987
Phase I study of taxol administered as a short i.v. infusion daily for 5 daysJ L Grem, K D Tutsch, K J Simon, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1993
Phase II multicenter evaluation of prolonged murine monoclonal antibody 17-1A therapy in pancreatic carcinomaL M Weiner, E Harvey, K Padavic-Shaller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluationA Dowlati, J Haaga, S C Remick, et al.
The Journal of Biological Chemistry|October 21, 1994
Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cellsL Sun, G Wu, J K Willson, et al.
Cancer Research|April 1, 1989
Methotrexate and dipyridamole combination chemotherapy based upon inhibition of nucleoside salvage in humansJ K Willson, P H Fischer, S C Remick, et al.
Cancer Research|May 27, 1999
O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repairT P Spiro, S L Gerson, L Liu, et al.
Cancer Research|July 1, 1996
Evaluation of the FHIT gene in colorectal cancersS Thiagalingam, N A Lisitsyn, M Hamaguchi, et al.
Pageof 17